What is breast cancer risk with Depo-Provera?
D000367:Age Factors; D001943:Breast Neoplasms; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003710:Demography; D004194:Disease; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D007390:International Agencies; D017258:Medroxyprogesterone Acetate; D009369:Neoplasms; D009938:Organizations; D011153:Population; D011154:Population Characteristics; D011157:Population Dynamics; D012106:Research; D012107:Research Design; D018570:Risk Assessment; D013995:Time; D013997:Time Factors; D014480:United Nations; D014944:World Health Organization
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Age Factors; Breast Cancer; Cancer; Contraception; Contraceptive Agents, Female--beneficial effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--beneficial effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--beneficial effects; Contraceptive Agents--side effects; Control Groups; Demographic Factors; Depo-provera--beneficial effects; Depo-provera--side effects; Diseases; Evaluation; Family Planning; International Agencies; Longterm Effects; Medroxyprogesterone Acetate--beneficial effects; Medroxyprogesterone Acetate--side effects; Neoplasms; Organizations; Population; Population Characteristics; Population Dynamics; Research Methodology; Research Report; Risk Assessment; Time Factors; Un; Who